Delivery Order SPE2DB20D1100-SPE2DB25FC1B1

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (Tirzepatide) 15 mg/0.5 ml pens. The contract has a firm fixed price of $4,590.11 and a period of performance through May 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a ceiling value of $2,629.79 and a period of performance ending on May 1, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (Tirzepatide) 15 mg/0.5 ml pens. The contract has a firm fixed price, a ceiling value of $15,645.27, and an ultimate completion date of May 5, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $29,500.48, is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,418.73, is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens, with a ceiling value of $11,093.27 and a period of performance through April 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,558.18, is for the supply of the diabetes medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has an ultimate completion date of April 11, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro (tirzepatide) 10 mg/0.5 ml pens, a diabetes medication. The contract is a firm fixed price delivery order with a ceiling value of $1,843.66 and a period of performance through May 1, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $7,453.05 and a period of performance through April 18, 2025. The contract is for the procurement of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $2,808.77 and a period of performance through May 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC1B1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (tirzepatide) 10 mg/0.5 mL pens. The contract has a firm fixed price of $1,632.54 and a period of performance ending on May 5, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is one of multiple orders that can be placed under the IDC to support federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/3/25, 1:31 AM